Philip R. Hagerman, Director, 10% Owner at Diplomat Pharmacy, Inc. (DPLO), sold 2,825,000 shares at $20.65 ($58.3M) on 2018-03-09, disclosed to the SEC on 2018-03-12.
Open-market sale of $58.3M DPLO by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.65 | 60,000 | $1.2M | 2.1% |
| 2 | $20.65 | 75,000 | $1.5M | 2.7% |
| 3 | $20.65 | 140,000 | $2.9M | 5.0% |
| 4 | $20.65 | 169,657 | $3.5M | 6.0% |
| 5 | $20.65 | 169,657 | $3.5M | 6.0% |
| 6 | $20.65 | 279,131 |
| $5.8M |
| 9.9% |
| 7 | $20.65 | 279,131 | $5.8M | 9.9% |
| 8 | $20.65 | 301,212 | $6.2M | 10.7% |
| 9 | $20.65 | 301,212 | $6.2M | 10.7% |
| 10 | $20.65 | 500,000 | $10.3M | 17.7% |
| 11 | $20.65 | 550,000 | $11.4M | 19.5% |
| Total | $20.65 avg | 2,825,000 | $58.3M | 100% |
| Filing → |
| DPLO | SELL | 2018-09-13 | $6.9M | — | Filing → |
| DPLO | SELL | 2015-12-08 | $38.2M | — | Filing → |
| DPLO | SELL | 2015-03-27 | $38.5M | — | Filing → |